These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 8218422

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A facile synthesis of 1-O-alkyl-2-(R)-hydroxypropane-3-phosphonocholine (lyso-phosphono-platelet activating factor).
    Schmitt JD, Nixon AB, Emilsson A, Daniel LW, Wykle RL.
    Chem Phys Lipids; 1992 Oct; 62(3):263-8. PubMed ID: 1468125
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Quantification of cholesterol tracers by gas chromatography--negative ion chemical ionization mass spectrometry.
    Ostlund RE, Hsu FF, Bosner MS, Stenson WF, Hachey DL.
    J Mass Spectrom; 1996 Nov; 31(11):1291-6. PubMed ID: 8946736
    [Abstract] [Full Text] [Related]

  • 26. Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS).
    Lee SH, Blair IA.
    Methods Enzymol; 2007 Nov; 433():159-74. PubMed ID: 17954234
    [Abstract] [Full Text] [Related]

  • 27. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
    Antonopoulou S, Tsoupras A, Baltas G, Kotsifaki H, Mantzavinos Z, Demopoulos CA.
    Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473
    [Abstract] [Full Text] [Related]

  • 28. A novel method for the analysis of platelet-activating factor: direct derivatization of glycerophospholipids.
    Satsangi RK, Ludwig JC, Weintraub ST, Pinckard RN.
    J Lipid Res; 1989 Jun; 30(6):929-37. PubMed ID: 2794783
    [Abstract] [Full Text] [Related]

  • 29. A gas chromatograph/resonant electron capture-TOF mass spectrometer for four dimensions of negative ion analytical information.
    Voinov VG, Vasil'ev YV, Ji H, Figard B, Morré J, Egan TF, Barofsky DF, Deinzer ML.
    Anal Chem; 2004 May 15; 76(10):2951-7. PubMed ID: 15144209
    [Abstract] [Full Text] [Related]

  • 30. Evidence for lipid packaging in the crystal structure of the GM2-activator complex with platelet activating factor.
    Wright CS, Mi LZ, Rastinejad F.
    J Mol Biol; 2004 Sep 10; 342(2):585-92. PubMed ID: 15327957
    [Abstract] [Full Text] [Related]

  • 31. Mass spectrometric characterization of substituted 2-thiazolin-4-one derivatives.
    Giorgi G, Salvini L, Attanasi OA, Filippone P, Santeusanio S.
    J Mass Spectrom; 2002 Jul 10; 37(7):709-15. PubMed ID: 12125004
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Electrospray tandem mass spectrometric study of ferrocene carbamate ester derivatives of saturated primary, secondary and tertiary alcohols.
    Quirke JM, Van Berkel GJ.
    J Mass Spectrom; 2001 Feb 10; 36(2):179-87. PubMed ID: 11288200
    [Abstract] [Full Text] [Related]

  • 34. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
    Whitehead SN, Hou W, Ethier M, Smith JC, Bourgeois A, Denis R, Bennett SA, Figeys D.
    Anal Chem; 2007 Nov 15; 79(22):8539-48. PubMed ID: 17949058
    [Abstract] [Full Text] [Related]

  • 35. Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology.
    White DC, Geyer R, Cantu J, Jo SC, Peacock AD, Saxton AM, Mani S, Jett M, Moss OR.
    J Microbiol Methods; 2005 Sep 15; 62(3):293-302. PubMed ID: 15963585
    [Abstract] [Full Text] [Related]

  • 36. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
    Chakrabarti R, Hubbard NE, Lim D, Erickson KL.
    Cell Immunol; 1997 Jan 10; 175(1):76-84. PubMed ID: 9015191
    [Abstract] [Full Text] [Related]

  • 37. Elevated circulating concentrations of platelet activating factor in preeclampsia.
    Rowland BL, Vermillion ST, Roudebush WE.
    Am J Obstet Gynecol; 2000 Oct 10; 183(4):930-2. PubMed ID: 11035340
    [Abstract] [Full Text] [Related]

  • 38. Method development for the determination of residual fluorotelomer raw materials and perflurooctanoate in fluorotelomer-based products by gas chromatography and liquid chromatography mass spectrometry.
    Larsen BS, Stchur P, Szostek B, Bachmura SF, Rowand RC, Prickett KB, Korzeniowski SH, Buck RC.
    J Chromatogr A; 2006 Mar 31; 1110(1-2):117-24. PubMed ID: 16473361
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Thin-layer and high-performance liquid chromatographic separation of glycerolipid subclasses as benzoates. Derivatives of ether and ester analogues of phosphatidylcholine, phosphatidylethanolamine and platelet activating factor.
    Blank ML, Cress EA, Fitzgerald V, Snyder F.
    J Chromatogr; 1990 Jun 01; 508(2):382-5. PubMed ID: 2370284
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.